This announcement is a separate document:
上海医药集团股份有限公司关于培哚普利叔丁胺原料药上市申请获得批准的公告
Announcement of Shanghai Pharmaceutical Group Co., Ltd. on approval of the marketing application for perindopril tert-butylamine
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.